APPLICATION
ANDA090402
TYPE
ANDA
ORIGINAL APPROVAL
2010-07-01
LATEST ACTION
2025-05-07
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
TACROLIMUSDiscontinued
TACROLIMUS EQ 5MG BASE · CAPSULE · ORAL
Approval history
2025-05-07Labeling · Supplement 4 · standardAP
2010-07-01OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.